Earnings Call · Q4 FY2022·2023-03-08

Q4 22EPS +2.94%·Rev n/aQ3 22EPS +5.56%·Rev n/aQ2 22EPS +20.75%·Rev n/aQ1 22EPS +15.22%·Rev n/a⚠ consensus missing

Mirum Pharmaceuticals, Inc. MIRM

Andrew McKibben — Host

Chris Peetz — President and CEO

Peter Radovich — Chief Operating Officer

Pamela Vig — Head of R&D

Ian Clements — Chief Financial Officer

−1.0%1d on move date+0.8% vs SPY3d−4.6%5d−0.5%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more MIRM calls or request research access.

More MIRM calls Browse calls Request research access